GPRIN1 and gastric cancer: The findings indicated that miR-654-5p downregulation inhibited GC cell proliferation and motion, while transfection of sh-GPRIN1 rescued the inhibitory effects of miR-654-5p inhibitor on GC cells (Figure 4a–d).